- Home
- BCE vs PODD Comparison
BCE vs PODD Comparison
Compare BCE & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCE
- PODD
- Stock Information
- Founded
- BCE 1880
- PODD 2000
- Country
- BCE Canada
- PODD United States
- Employees
- BCE 40390
- PODD N/A
- Industry
- BCE
- PODD Medical/Dental Instruments
- Sector
- BCE
- PODD Health Care
- Exchange
- BCE Nasdaq
- PODD Nasdaq
- Market Cap
- BCE 21.3B
- PODD 22.1B
- IPO Year
- BCE N/A
- PODD 2007
- Fundamental
- Price
- BCE $23.07
- PODD $329.10
- Analyst Decision
- BCE Hold
- PODD Strong Buy
- Analyst Count
- BCE 3
- PODD 18
- Target Price
- BCE $29.50
- PODD $354.17
- AVG Volume (30 Days)
- BCE 2.9M
- PODD 565.0K
- Earning Date
- BCE 11-06-2025
- PODD 11-06-2025
- Dividend Yield
- BCE 5.48%
- PODD N/A
- EPS Growth
- BCE 7324.86
- PODD N/A
- EPS
- BCE 4.80
- PODD 3.45
- Revenue
- BCE $17,579,277,614.00
- PODD $2,521,800,000.00
- Revenue This Year
- BCE $2.01
- PODD $29.32
- Revenue Next Year
- BCE $3.06
- PODD $18.37
- P/E Ratio
- BCE $4.81
- PODD $95.05
- Revenue Growth
- BCE 0.11
- PODD 27.11
- 52 Week Low
- BCE $20.28
- PODD $230.05
- 52 Week High
- BCE $27.50
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- BCE 47.54
- PODD 54.67
- Support Level
- BCE $22.71
- PODD $311.51
- Resistance Level
- BCE $23.17
- PODD $341.03
- Average True Range (ATR)
- BCE 0.46
- PODD 11.91
- MACD
- BCE 0.02
- PODD 1.18
- Stochastic Oscillator
- BCE 52.47
- PODD 75.76
About BCE BCE Inc.
BCE provides wireless, broadband, television, and landline phone services in Canada. It is one of the Big Three national wireless carriers, with over 10 million customers constituting about 30% of the market. It is also the incumbent local exchange carrier—the legacy telephone provider—throughout much of the eastern half of Canada, including in the most populous Canadian provinces: Ontario and Quebec. BCE has a media segment that holds television, radio, and digital media assets. BCE licenses the Canadian rights to HBO Max and Starz.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.